Cardiac Myosin Inhibitor class drugs
1 result
Camzyos (mavacamten)
(mavacamten)Myokardia, Inc.
Usage: CAMZYOS® is indicated for adults with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (HCM) to enhance functional capacity and alleviate symptoms.